TIDMCLL

RNS Number : 7452U

Cello Group plc

26 October 2017

26 October 2017

Cello Group plc

("Cello" or the "Company")

Director/PDMR Shareholding

The Company has been notified that, on 26 October 2017, Alistair Shirley, a person closely associated with Jane Shirley, CEO of Cello Health Europe and Cello Health Insight, purchased 2,000 ordinary shares of 10 pence each in the capital of the Company, at a price of approximately 133 pence per share.

Following the above transaction, Jane Shirley and her persons closely associated hold 80,000 ordinary shares, representing approximately 0.1% of the Company's issued ordinary share capital.

Enquiries:

 
 Cello Group                       020 7812 8460 
 Mark Scott, Chief Executive 
 Mark Bentley, Finance Director 
 
 Cenkos Securities                 0207 397 8900 
 Bobbie Hilliam 
  Harry Hargreaves 
 
 
 1    Details of the person discharging managerial 
       responsibilities / person closely associated 
---  ------------------------------------------------------- 
 a)   Name                       Alistair Shirley 
---  -------------------------  ---------------------------- 
 2    Reason for the notification 
---  ------------------------------------------------------- 
 a)   Position/status            Person closely associated 
                                  with Jane Shirley 
---  -------------------------  ---------------------------- 
 b)   Initial notification       Initial notification 
       /Amendment 
---  -------------------------  ---------------------------- 
 3    Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  ------------------------------------------------------- 
 a)   Name                       Cello Group plc 
---  -------------------------  ---------------------------- 
 b)   LEI                        2138004TZYGZLWQP7N64 
---  -------------------------  ---------------------------- 
 4    Details of the transaction(s): section to 
       be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  ------------------------------------------------------- 
 a)   Description of             Ordinary Shares of 10p each 
       the financial 
       instrument, type 
       of instrument              GB00B0310763 
 
       Identification 
       code 
---  -------------------------  ---------------------------- 
 b)   Nature of the              Purchase of Ordinary Shares 
       transaction 
---  -------------------------  ---------------------------- 
 c)   Price(s) and volume(s)       Price(s)    Volume(s) 
                                   ----------  ---------- 
                                    132.9999p   2,000 
                                   ----------  ---------- 
---  -------------------------  ---------------------------- 
 d)   Aggregated information 
 
       -Aggregated volume          2,000 
 
       -Price                      GBP2,660.00 
---  -------------------------  ---------------------------- 
 e)   Date of the transaction    26 October 2017 
---  -------------------------  ---------------------------- 
 f)   Place of the transaction   XLON 
---  -------------------------  ----------------------------

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHUNOORBSARUAA

(END) Dow Jones Newswires

October 26, 2017 09:37 ET (13:37 GMT)

Cello Health (LSE:CLL)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Cello Health Charts.
Cello Health (LSE:CLL)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Cello Health Charts.